CurAegis Technologies Inc (fka CRGS)

[Dino1717]

Todays Press Release extremely helpful to Mr Sotile in promoting Torvec. "The going concern notice" or as previously referred to as "that 900 pound gorilla sitting in the room" is now not hanging over his promotion of Torvec. Let's hope we go higher from here faithful Torvec longs


Item 8.01 Other Events.

On December 21, 2009, Torvec appointed Robert C. Sotile as Director of Capital Initiatives. Mr. Sotile has had extensive entrepreneurial experience and considerable background in capital development since 1994 as president and chief executive officer of numerous companies in the medical and pharmaceutical industries. He is presently CEO and CFO of PharmedUSA where he has developed strategic business opportunities in delivering medications to institutions at significant savings.

As Torvec’s Director of Capital Initiatives, Mr. Sotile will interface with his significant portfolio of clients in the medical and pharmaceutical fields in order to actively promote Torvec and its technologies.

Mr. Sotile is a large, long term Torvec investor who has enthusiastically agreed to furnish his considerable expertise to Torvec in a non compensated capacity.